Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial
- 作者Eli D. Ehrenpreis; Sunanda V. Kane; Lawrence B. Cohen; Russell D. Cohen; Stephen B. Hanauer
- 卷第117卷
- 期第6期
- 文件大小179.38KB
- 发表时间1999
- DOI10.1016/s0016-5085(99)70276-3
- 页码1271-1277
Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: A prospective and randomized clinical studyKaukinen, Katri; Peräaho, Markku; Collin, Pekka; Partanen, Jukka; Woolley, Nina; Kaartinen, Tanja; Nuutinen, Tuula; Halttunen, Tuula; Mäki, Markku; Korponay-Szabo, Ilma · Scandinavian Journal of Gastroenterology · 2005
Identification of Novel Transcription Factor-like Gene from Human Intestinal CellsKatri Lindfors; Tuula Halttunen; Paula Huotari; Nina Nupponen; Mauno Vihinen; Tapio Visakorpi; Markku Mäki; Heikki Kainulainen · 2000
Design, Synthesis, and Evaluation of Gluten Peptide Analogs as Selective Inhibitors of Human Tissue TransglutaminaseFelix Hausch; Tuula Halttunen; Markku Mäki; Chaitan Khosla · 2003
Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac diseaseSatu Sulkanen; Tuula Halttunen; Kaija Laurila; Kaija-Leena Kolho; Ilma R. Korponay-Szabó; Annikki Sarnesto; Erkki Savilahti; Pekka Collin; Markku Mäki · 1998
Differentially expressed CC3/TIP30 and rab11 along in vivo and in vitro intestinal epithelial cell crypt-villus axisKatri Lindfors; Tuula Halttunen; Heikki Kainulainen; Markku Mäki · 2001